Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genetic Signatures Ltd. (AU:GSS)
ASX:GSS
RESEARCH TOOLSreports
Holding AU:GSS?
Track your performance easily
GSS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.38 - AU$0.85
Previous CloseAU$0.72
Volume2.79K
Average Volume (3M)69.83K
Market Cap
AU$162.78M
Enterprise ValueAU$125.92M
Total Cash (Recent Filing)AU$36.90M
Total Debt (Recent Filing)AU$34.00K
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares OutstandingN/A
10 Day Avg. Volume27,818
30 Day Avg. Volume69,832
Standard Deviation0.15
R-Squared0.00925
Alpha0.00578
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)4.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genetic Signatures Ltd. News
PremiumCompany Announcements
Genetic Signatures: Director Samaras Departs, Shares in Focus
PremiumCompany Announcements
Genetic Signatures Ltd. Resolutions Passed at AGM
PremiumCompany Announcements
Genetic Signatures Reports Strong Sales Boost Amid U.S. Expansion
PremiumCompany Announcements
Genetic Signatures Announces Upcoming Annual General Meeting
PremiumCompany Announcements
Genetic Signatures Issues New Employee OptionsPremiumCompany Announcements
Genetic Signatures Director Steps DownPremiumCompany Announcements
Mercer Investments Becomes Major Shareholder in Genetic Signatures
PremiumCompany Announcements
Genetic Signatures Options Cease Amidst Unmet ConditionsOptions Prices
Currently, No data available
---
Ownership Overview
GSS FAQ
What was Genetic Signatures Ltd.’s price range in the past 12 months?
Genetic Signatures Ltd. lowest share price was AU$0.38 and its highest was AU$0.85 in the past 12 months.
What is Genetic Signatures Ltd.’s market cap?
Currently, no data Available
When is Genetic Signatures Ltd.’s upcoming earnings report date?
Genetic Signatures Ltd.’s upcoming earnings report date is Mar 04, 2025 which is in 101 days.
How were Genetic Signatures Ltd.’s earnings last quarter?
Genetic Signatures Ltd. released its earnings results on Aug 28, 2024. The company reported -AU$0.035 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.035.
Is Genetic Signatures Ltd. overvalued?
According to Wall Street analysts Genetic Signatures Ltd.’s price is currently Overvalued.
Does Genetic Signatures Ltd. pay dividends?
Genetic Signatures Ltd. does not currently pay dividends.
What is Genetic Signatures Ltd.’s EPS estimate?
Genetic Signatures Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Signatures Ltd. have?
Genetic Signatures Ltd. has 226,872,160 shares outstanding.
What happened to Genetic Signatures Ltd.’s price movement after its last earnings report?
Genetic Signatures Ltd. reported an EPS of -AU$0.035 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genetic Signatures Ltd.?
Currently, no hedge funds are holding shares in AU:GSS
---
Genetic Signatures Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:GSS Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
53.20%
12-Months-Change
Fundamentals
Return on Equity
-34.34%
Trailing 12-Months
Asset Growth
37.10%
Trailing 12-Months
Company Description
Genetic Signatures Ltd.
Genetic Signatures Ltd is a molecular diagnostics company. The company is engaged in the development and commercialization of its proprietary platform technology, 3Base. The firm operates under one business segment namely the research and commercialisation of identifying individual genetic signatures to identify diseases and disabilities. It offers various detection kits under the brand EasyScreen in order to detect different infectious diseases including gastroenteritis, respiratory diseases, meningitis pathogens, among others.
---
GSS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Cyclopharm Limited
―
Resonance Health Ltd
―
Medical Developments International Limited
―
OncoSil Medical Ltd
―
Best Analysts Covering GSS
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+14.37%
reiterated a buy rating 6 months ago
Copying Dennis Hulme's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +14.37% per trade.
---